9SB.F - SOL Global Investments Corp.

Frankfurt - Frankfurt Delayed Price. Currency in EUR
1.1376
+0.0386 (+3.51%)
At close: 4:48PM CEST
Stock chart is not supported by your current browser
Previous Close1.0990
Open1.1738
Bid1.1432 x 0
Ask1.2100 x 0
Day's Range1.1280 - 1.1738
52 Week Range0.7320 - 3.6800
Volume400
Avg. Volume52
Market Cap56.816M
Beta (3Y Monthly)N/A
PE Ratio (TTM)0.28
EPS (TTM)4.0340
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group3 days ago

    SOL Global to announce fiscal 2019 financial results and strategic corporate update post market close July 29, 2019

    TORONTO , July 19, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL (SOLCF) ) (9SB.F) expect to release results for the years ended March 31, 2019 as well as a comprehensive corporate update on July 29, 2019 after market close. SOL Global also expect to provide detail on the Company's NAV in the release to provide the market and analysts with clarity on the substantial delta between their intrinsic value versus today's stock price. The Company will host a conference call Wednesday, August 7th, 2019 to discuss the corporate update in-depth.

  • PR Newswire5 days ago

    SOL Global Announces US$6.5 Million Investment in CannCure

    TORONTO, July 17, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (CSE:SOL (SOLCF) ) (9SB.F) is pleased to announce a US$6.5 million capital infusion in its portfolio company CannCure Investments Inc. ("CannCure"), an investment that is intended to fuel the growth of its position throughout the cannabis markets of Florida, Michigan, and California.

  • SOL Global Announces $15 Million Investment into Heavenly Rx
    PR Newswire10 days ago

    SOL Global Announces $15 Million Investment into Heavenly Rx

    TORONTO, July 12, 2019 /PRNewswire/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (Frankfurt: 9SB) is pleased to announce that it has purchased 37,662,500 common shares ("Heavenly Shares") in the capital of Heavenly Rx Ltd. ("Heavenly Rx") at a price of $0.40 for an aggregate subscription amount of CAD$15,065,000.  The subscription is part of a larger private offering by Heavenly Rx of Heavenly Shares (the "Offering"). As a result of this subscription, SOL Global now holds 42.0% of the issued and outstanding Heavenly Shares and the other shareholders of Heavenly Rx collectively hold the remaining 58.0%. The Heavenly Shares are subject to an indefinite hold period under applicable Canadian securities laws.

  • SOL Global Completes $50 Million Debenture Financing and Announces Corporate Update
    CNW Group14 days ago

    SOL Global Completes $50 Million Debenture Financing and Announces Corporate Update

    The Company intends to use the net proceeds for working capital and general corporate purposes and to primarily finance the continued build-out of SOL Global's robust hemp and CBD strategy via Heavenly Rx Ltd. and the build-out and acquisition of additional assets in Florida , Michigan and California for its previously-announced, new cannabis multi-state operator. The funds are expected to help ensure the execution of the Company's long term vision, strategic acquisitions and its ongoing investment in top-tier talent and operations across both its hemp/CBD and THC operations. The Debenture bears an interest rate of 6.0% per annum and will mature two (2) years from the date of closing, unless such maturity date is otherwise shortened due to the occurrence of certain independent milestones as set out within the terms and conditions of the Debenture.

  • CNW Group2 months ago

    SOL Global Investments Corp. Acquires Securities of Frankly Inc.

    SOL Global Investments Corp. Acquires Securities of Frankly Inc.

  • SOL Global Portfolio Company Heavenly Rx Announces Key Leadership Appointments
    CNW Group2 months ago

    SOL Global Portfolio Company Heavenly Rx Announces Key Leadership Appointments

    TORONTO , June 3, 2019 /CNW/ - Heavenly Rx Ltd., the international hemp and CBD-focused portfolio company of SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce key leadership appointments today, including bringing on two distinguished business personalities as Chief Executive Office and Chief Operating Officer. It is with great pleasure that SOL Global today announces the appointment of Paul Norman , former President of North America for the $13B food giant Kellogg, to serve as Chief Executive Officer and Chairman of its portfolio company, Heavenly Rx Ltd. ("Heavenly Rx"), effective immediately.

  • CNW Group2 months ago

    /R E P E A T -- SOL Global and Goldstream Minerals Announce Proposed Reverse Takeover By CannCure Investments/

    TORONTO , May 30, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global") (SOL.CN) (SOLCF) (9SB.F) and Goldstream Minerals Inc. (GSX-H.V) ("Goldstream" or the "Company") are pleased to announce that Goldstream and CannCure Investments Inc. ("CannCure"), a portfolio company of SOL Global, have entered into a letter of intent dated as of May 29, 2019 (the "LOI") outlining the proposed terms and conditions pursuant to which Goldstream and CannCure will effect a business combination that will result in a reverse takeover of Goldstream by the shareholders of CannCure (the "Proposed Transaction"). The entity resulting from the Proposed Transaction (the "Resulting Issuer") will continue to carry on the business of CannCure as a multi-state vertically integrated cannabis company (the "MSO").

  • CNW Group2 months ago

    SOL Global and Goldstream Minerals Announce Proposed Reverse Takeover By CannCure Investments

    TORONTO , May 30, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global") (SOL.CN) (SOLCF) (9SB.F) and Goldstream Minerals Inc. (GSX-H.V) ("Goldstream" or the "Company") are pleased to announce that Goldstream and CannCure Investments Inc. ("CannCure"), a portfolio company of SOL Global, have entered into a letter of intent dated as of May 29, 2019 (the "LOI") outlining the proposed terms and conditions pursuant to which Goldstream and CannCure will effect a business combination that will result in a reverse takeover of Goldstream by the shareholders of CannCure (the "Proposed Transaction"). The entity resulting from the Proposed Transaction (the "Resulting Issuer") will continue to carry on the business of CannCure as a multi-state vertically integrated cannabis company (the "MSO").

  • SOL Global Adds California to Its MSO Portfolio with Proposed Acquisition of Premiere Cultivation, Processing, and Dispensary Companies
    CNW Group2 months ago

    SOL Global Adds California to Its MSO Portfolio with Proposed Acquisition of Premiere Cultivation, Processing, and Dispensary Companies

    TORONTO , May 16, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that it has entered into letters of intent to acquire ECD, Inc., which operates as Northern Emeralds ("Northern Emeralds"), an industry leading cannabis cultivation, processing and distribution company headquartered in Humboldt County, California , as well as six (6) licensed dispensary companies in California that will subsequently operate under the nationally recognized "One Plant" brand. SOL Global intends to open One Plant -branded dispensaries throughout California (a total of 20 operating and licensed dispensary companies), Florida , and Michigan .

  • SOL Global Signs Binding Agreement with Merida Capital Partners' Subsidiary to Acquire Michigan Fully Licensed Cannabis Business
    CNW Group3 months ago

    SOL Global Signs Binding Agreement with Merida Capital Partners' Subsidiary to Acquire Michigan Fully Licensed Cannabis Business

    TORONTO , April 24, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F), the owner of 3 Boys Farms, LLC ("3 Boys"), which holds one of Florida's original 14 operating and vertically integrated medical marijuana treatment center licenses, is pleased to announce that it has entered into a binding letter of intent ("LOI") with cannabis-focused private equity firm Merida Capital Partners ("Merida") dated April 23, 2019 to acquire Merida's Michigan subsidiary, MCP Wellness, Inc. ("MCP Wellness") for an aggregate purchase price of US$150 million (the "Acquisition"). MCP Wellness, a special-purpose vehicle (SPV) created to invest in Michigan cannabis operations, currently holds the rights to acquire two Michigan cultivation licenses, a processing license, and 3 fully licensed cannabis provisioning centers in Michigan with a fourth provisioning center scheduled to open in Ann Arbor in May.

  • SOL Global Announces 3 Boys Farms' Receipt of Approval to Dispense Cannabis Flower and Pre-Roll Products in Florida
    CNW Group3 months ago

    SOL Global Announces 3 Boys Farms' Receipt of Approval to Dispense Cannabis Flower and Pre-Roll Products in Florida

    TORONTO , April 22, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that 3 Boys Farms, LLC ("3 Boys Farm"), which owns and operates one of the twenty-two (22) medical marijuana treatment center licenses in Florida , has received approval from the State of Florida's Department of Health, Office of Medical Marijuana Use ("OMMU") to begin dispensing its premium, organically cultivated cannabis flower and pre-rolled products at its new state-of-the-art extraction and processing facility in Indiantown, Florida . SOL Global completed its acquisition of 3 Boys Farms earlier this month through the closing of its purchase of CannCure Investments Inc.

  • SOL Global's CBD and Hemp Portfolio Company, Heavenly Rx, Closes Private Placement Financing of Over $12 Million
    CNW Group3 months ago

    SOL Global's CBD and Hemp Portfolio Company, Heavenly Rx, Closes Private Placement Financing of Over $12 Million

    TORONTO , April 18, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that it has completed multiple tranches of a non-brokered private placement financing of common shares of its subsidiary, Heavenly Rx Ltd. ("Heavenly Rx"), for aggregate gross proceeds of $12,586,250 (the "Offering"). An aggregate of 125,862,500 common shares in the capital of Heavenly Rx ("Heavenly Shares") were issued and sold at a price of $0.10 per Heavenly Share. As a result of this financing, SOL Global now holds 34.40% of the issued and outstanding Heavenly Shares with the subscribers from the Offering collectively holding the remaining 65.60%.

  • SOL Global Completes Acquisition of 3 Boys Farms through the Purchase of CannCure Investments Inc.
    CNW Group3 months ago

    SOL Global Completes Acquisition of 3 Boys Farms through the Purchase of CannCure Investments Inc.

    Pursuant to the terms of an amended and restated share purchase agreement (the "Amended Purchase Agreement") between the Company, CannCure and the shareholders of CannCure (the "Sellers"), SOL Global acquired all of the issued and outstanding common shares of CannCure for a revised purchase price of US$41,207,519 , which was partially satisfied by the issuance of 7,317,500 common shares of SOL Global ("Consideration Shares") at a negotiated price of CAD $4.00 per share to the Sellers on a pro-rata basis.

  • GlobeNewswire3 months ago

    Exactus Applauds Executive Chairman, Jonathan Gilbert on Launch of Impact Biosciences Corp.

    Exactus Inc. (EXDI), a healthcare company pursuing opportunities in Hemp derived Cannabidiol (CBD) products, applauds its Executive Chairman of the Board, Jonathan Gilbert, on the launch of Impact Biosciences Corp. Jonathan Gilbert, cannabis industry veteran, and founder and former CEO of SOL Global Investments Corp. (CSE:SOL) (9SB.F) (SOLCF), whose wholly owned subsidiary, Scythian Biosciences Inc. (“SBI”), is seeking to list SBI as a new public company on the Canadian Stock Exchange (“CSE”) following a successful capital raise and spinout.

  • SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary
    CNW Group4 months ago

    SOL Global to Spin Off Cannabinoid Drug Therapy Research and Development Subsidiary

    TORONTO , April 5, 2019 /CNW/ - SOL Global Investments Corp. ("SOL" or the "Company") (SOL.CN) (9SB.F) (SOLCF)  is pleased to announce that it intends to spin off its wholly-owned subsidiary, Scythian Biosciences Inc. ("SBI"), into an independent, publicly-traded company (the "Spin-off"). In connection with the Spin-off, SBI will be renamed "Impact Biosciences Corp" ("Impact") and will continue to pursue a drug development in the United States for the treatment of concussions and traumatic brain injury with its proprietary Cannabinoid combination drug candidate, which is being developed under contract with the University of Miami . Impact's mission is to become the first accepted drug regimen for concussive treatment.

  • SOL Global Announces 3 Boys Farms' Receipt of Approval for Cannabis Processing and Dispensing in State of Florida
    CNW Group4 months ago

    SOL Global Announces 3 Boys Farms' Receipt of Approval for Cannabis Processing and Dispensing in State of Florida

    TORONTO , April 3, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that 3 Boys Farms, LLC ("3 Boys Farm"), which owns and operates one of the fourteen medical marijuana treatment center licenses in Florida , has received approval from the State of Florida's Department of Health, Office of Medical Marijuana Use ("OMMU") to begin processing and dispensing cannabis products at its new state-of-the-art extraction and processing facility in Indiantown, Florida . SOL Global is in the process of acquiring 3 Boys Farms through its previously announced acquisition of CannCure Investments Inc. ("Canncure") pursuant to a binding share purchase agreement.

  • SOL Global Acquires 10.3 Percent Stake in Premium Beauty and Wellness Company Sacred Hemp
    CNW Group4 months ago

    SOL Global Acquires 10.3 Percent Stake in Premium Beauty and Wellness Company Sacred Hemp

    TORONTO , April 2, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce its latest strategic investment, a significant position in premium hemp company Sacred Hemp ("Sacred"). SOL Global has acquired a 10.3 percent stake in Sacred, the Chicago, Illinois -based manufacturer of premium hempseed oil-infused products including pain relief balms and oils, feminine products, massage oils, salt soaks, and personal lubricants. Sacred's product line includes its bestselling all-natural pain relief balms and lotions, made from a combination of natural hempseed oil extracts, essential oils, and menthol.

  • SOL Global Signs Termination Agreement with Verano Holdings over Sale of 3 Boys Farms
    CNW Group4 months ago

    SOL Global Signs Termination Agreement with Verano Holdings over Sale of 3 Boys Farms

    TORONTO , April 1, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) announces the termination of its agreement with Verano Holdings, LLC ("Verano") to sell a 100% interest in 3 Boys Farms LLC ("3 Boys Farms"), a Florida -licensed medical cannabis company which SOL Global was in the process of acquiring, to Verano. As announced on October 23, 2018 , the Company had entered into a binding contribution agreement to sell a 100% interest in 3 Boys Farms, which included 100% ownership in one of Florida's fourteen (14) vertically integrated medical cannabis licenses to Verano in exchange for USD$100 million of Class B units in Verano.

  • SOL Global Increases Stake in Jones Soda to 9.8 Percent
    CNW Group4 months ago

    SOL Global Increases Stake in Jones Soda to 9.8 Percent

    TORONTO , March 28, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce it has increased its investment in premium soda-maker Jones Soda Co. (" Jones Soda ") (JSDA). SOL Global has acquired a total of 4,066,048 common shares of Jones Soda , or approximately 9.8 percent of the total issued and outstanding common shares of Jones Soda . SOL Global has filed an amendment to the Schedule 13D that the Company had previously filed with the United States Securities and Exchange Commission describing its additional investment in Jones Soda .

  • SOL Global Acquires 8 Percent Stake in Iconic Soda Company Jones Soda
    CNW Group4 months ago

    SOL Global Acquires 8 Percent Stake in Iconic Soda Company Jones Soda

    TORONTO , March 26, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce its investment in leading premium soda-maker Jones Soda Co. (" Jones Soda ") (JSDA). SOL Global has acquired 3,396,049 common shares of Jones Soda in the open market. SOL Global's total investment represents approximately 8.19% of the total issued and outstanding common shares of Jones Soda which, based on publicly available information, makes it the company's largest stockholder.

  • SOL Global Announces Receipt of Approval for Sale and Transfer of Florida 3 Boys Farms Operations and Assets
    CNW Group4 months ago

    SOL Global Announces Receipt of Approval for Sale and Transfer of Florida 3 Boys Farms Operations and Assets

    TORONTO , March 11, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is excited to announce that the Company has received approval from the Florida Department of Health for the sale and transfer of the 3 Boys Farm ("3 Boys") license from CannCure Investments Inc. ("CannCure") to SOL Global. The approval includes the transfer of all operations and assets, including farms and dispensaries.

  • SOL Global Subsidiary Heavenly Rx Announces Acquisition of 568 Acres of Hemp Farms for Biomass Production
    CNW Group5 months ago

    SOL Global Subsidiary Heavenly Rx Announces Acquisition of 568 Acres of Hemp Farms for Biomass Production

    TORONTO , March 7, 2019 /CNW/ - SOL Global Investments Corp. ("SOL Global" or the "Company") (SOL.CN) (SOLCF) (9SB.F) is pleased to announce that it has signed a binding letter of intent ("LOI") to acquire three tracts of agricultural property totaling 568 acres of land in the States of Tennessee and Kentucky for the cultivation and production of raw hemp biomass. The Company will assign the agricultural property to its hemp/CBD-focused subsidiary, Heavenly Rx Ltd. ("Heavenly").